Roth Capital raised the firm’s price target on Occidental (OXY) to $46 from $45 and keeps a Neutral rating on the shares. The company announced an agreement to sell its OxyChem business to Berkshire Hathaway (BRK.B) (BRK.A) (BRK) for $9.7B in an all-cash transaction with expected after-tax proceeds of $8.0B, though this was slightly below previous reports in the media of an approximate $10B sale price, the analyst tells investors in a research note. The $6.5B debt paydown will also allow Occidental to hit its corporate debt target of less than $15B by 2025-end, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXY:
- Occidental Petroleum Sells OxyChem to Berkshire Hathaway
- Occidental appoints Richard Jackson as SVP, COO
- Berkshire Hathaway to acquire OxyChem from Occidental for $9.7B
- Warren Buffett May Score Again as Berkshire Weighs $10B Deal for Occidental Chemical
- Warren Buffett’s Berkshire Hathaway (BRK.B) Plans to Buy OxyChem for $10 Billion